The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

REFILE-EU drugs watchdog expects first application for COVID-19 vaccine in days

Thu, 26th Nov 2020 11:06

(Fixes typographical error in headline)

BRUSSELS, Nov 26 (Reuters) - Europe's drugs watchdog said on
Thursday it expects to receive the first application for
conditional marketing approval for a COVID-19 vaccine "in the
coming days", the latest step towards making a shot available
outside the United States.

The European Medicines Agency (EMA) did not name the company
it expects to file the application, but Pfizer Inc and
BioNTEch are the most advanced in the regulatory
process among the three companies that have published late-stage
trial data for their vaccines.

(Reporting by Francesco Guarascio in Brussels;
Writing by Josephine Mason in London
Editing by David Goodman)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.